Unit I KANDLA, GUJARAT Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Tablets

10 Million

Coated Tablets

1 Million

 General Capsules

788 Million

β-Lactum Capsules

613 Million

Sachet

221 Million

β-Lactum dry Syrup

26 Million

Vials

53 Million

Glass Ampoule

48 Million

Plastic Ampoule

1.5 Million

Cream & Ointment

11 Millions

Approved by

  • WHO (India)
  • State GMP
  • South Africa(MCC/SAHPRA)
  • Kenya - PPB
  • India - CDSCO

Unit II KANDLA, GUJARAT Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Transdermal Patches

10.8 Million

GMP certification

  • State GMP

DEHRADUN, UTTARAKHAND Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Tablets

4300 Million

Capsules

21 Million

Sachet

21 Million

Transdermal Patches 

8.64 Million

Granules

4000 kg

Vials

40 Million

Bottles

0.1 Million

Ampoule

90 Million

Pre Filled Syring

15 Million

Syrup

9.36 Millions Bottles

Approved by

  • WHO (India)
  • IDA
  • State GMP
  • Ukraine – PIC/S
  • Kenya - PPB
  • Namibia
  • Tanzania - TFDA

Ankleshwar, GUJARAT API Facility

API Manufacturing facility is Approved by:

  • EDQM - Spain
  • WHO (India)
  • State GMP